Multiple sclerosis (MS) remains the major cause of neurologic deficit and disability in young people—those who are establishing themselves professionally and personally and generating a reserve that is to support them and their families throughout the rest of their lives. Disruption at this stage of life has wide-reaching consequences for them personally, their families, and their professional colleagues, affecting all levels of performance. In 2009, there was an estimated 572 312 patients with MS worldwide.1 For noninstitutionalized patients, additional health care costs per year were $24 327 per patient compared with the healthy community, not taking into account lost productivity or early retirement.
White OB, Costello F. Melanopsin Effects on Pupil Responses: Is the Eye the Window to the Weary Soul? JAMA Neurol. 2017;74(5):506–508. doi:10.1001/jamaneurol.2016.5385
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: